Methods of making gels and films using curli nanofibers
US-11098133-B2 · Aug 24, 2021 · US
US11352397B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11352397-B2 |
| Application number | US-201916713368-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 13, 2019 |
| Priority date | Apr 23, 2013 |
| Publication date | Jun 7, 2022 |
| Grant date | Jun 7, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods and compositions relating to engineered curli fibers, e.g. CsgA polypeptide. In some embodiments, the methods and compositions described herein relate to functionalized biofilms.
Opening claim text (preview).
What is claimed herein is: 1. An engineered CsgA polypeptide comprising a wild-type Escherichia coli ( E. coli ) CsgA polypeptide with a C-terminal display tag flanking the CsgA, wherein the display tag comprises an activity polypeptide and a flexible polypeptide linker sequence, wherein the linker sequence is located N-terminal to the display tag, wherein the activity polypeptide comprises a binding domain selected from the group consisting of SpyTag peptide, metal binding domain (MBD) peptide, graphene binding peptide (GBP), carbon nanotube binding peptide (CBP), gold binding A3 peptide, ZnS quantum dot templating CT43 peptide, FLAG affinity tag peptide, ZnS quantum dot templating Z8 peptide, CdS quantum dot templating E14 peptide, quartz/glass binding QBP1 peptide, hydroxyapatite templating CLP12 peptide, ice crystal binding AFP8 peptide, biotin acceptor peptide (BAP), biotin carboxyl carrier protein (BCCP), and a peptide comprising a LPXTG (SEQ ID NO: 23) motif. 2. The CsgA polypeptide of claim 1 , wherein the linker sequence consists of glycine and serine residues. 3. A composition comprising the engineered CsgA polypeptide of claim 1 . 4. The composition of claim 3 , wherein the composition comprises filaments comprising the engineered CsgA polypeptide of claim 1 . 5. The composition of claim 3 , wherein the composition comprises a proteinaceous network. 6. The composition of claim 3 , wherein the composition further comprises proteinaceous biofilm components. 7. The composition of claim 3 , wherein the composition further comprises an engineered microbial cell comprising a vector or nucleic acid sequence encoding the engineered CsgA polypeptide. 8. The composition of claim 3 , wherein the composition further comprises a functionalizing polypeptide comprising an interacting domain.
Antibacterial agents · CPC title
Escherichia (G) · CPC title
containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title
containing a tag with affinity for a non-protein ligand · CPC title
from Pseudomonadaceae (F) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.